On October 1, 2016, Pharma Start celebrates a significant date - 1 year since its integration into the close-knit family of the Swiss pharmaceutical group of companies Acino Pharma AG (hereinafter - ACINO). The integration of Pharma Start into ACINO is one of the largest investments in the Ukrainian economy over the past 5 years. The company is among the top 10 local pharmaceutical companies in Ukraine *. On the eve of the happy date, many guests visited Pharma Start. So, on September 6, 2016, the Ambassador of Switzerland to Ukraine and the Republic of Moldova, Mr. Guillaume Scheurer, paid a familiarization visit to the company, for whom a special tour of the pharmaceutical company Pharma Start of the Swiss pharmaceutical group ACINO in Kiev was conducted. During the visit, Mr. Ambassador was pleasantly surprised by what he saw and expressed hope that the conditions for foreign investors in Ukraine will continue to improve.
Product descriptionAmantin tablets are used for the following indications:Parkinson's syndrome: treating symptoms of Parkinson's disease such as rigidity, tremors, hypokinesia and akinesia;extrapyramidal side effects of antipsychotics and other preparations: early dyskinesia, akathisia and parkinson..
Pharmacological propertiesPharmacodynamics. Mechanism of action. The therapeutic effect of aripiprazole in the treatment of schizophrenia and bipolar I disorder is due to a combination of partial agonism for dopamine d2 and serotonin 5-ht1a receptors, as well as antagonism for serotonin 5-ht2a recep..
Pharmacological propertiesPharmacodynamics. Mechanism of action. The therapeutic effect of aripiprazole in the treatment of schizophrenia and bipolar I disorder is due to a combination of partial agonism for dopamine d2 and serotonin 5-ht1a receptors, as well as antagonism for serotonin 5-ht2a recep..
Pharmacological propertiesPharmacodynamics. Mechanism of action. The therapeutic effect of aripiprazole in the treatment of schizophrenia and bipolar I disorder is due to a combination of partial agonism for dopamine d2 and serotonin 5-ht1a receptors, as well as antagonism for serotonin 5-ht2a recep..
Pharmacological propertiesPharmacodynamics. Rosuvastatin is a selective competitive inhibitor of hmg-coa reductase, an enzyme that converts hmg-coa into mevalonate, a precursor of chs. the main site of action of rosuvastatin is the liver, where the synthesis of xc and LDL catabolism is carried out.R..
Pharmacological propertiesPharmacodynamics. Rosuvastatin is a selective competitive inhibitor of hmg-coa reductase, an enzyme that converts hmg-coa into mevalonate, a precursor of chs. the main site of action of rosuvastatin is the liver, where the synthesis of xc and LDL catabolism is carried out.R..
Pharmacological propertiesCorvaltab is a sedative, vasodilator, antispasmodic agent. helps to reduce the excitability of the central nervous system, has a calming effect and facilitates the onset of natural sleep. ethyl ester of α-bromisovaleric acid, which is part of the preparation Corv..
Pharmacological propertiesPharmacodynamics. Vasodilator (coronarolytic), sedative, hypnotic. has a mild antianginal effect. helps to reduce the excitability of the central nervous system, has a calming effect and facilitates the onset of natural sleep.Ethyl ester of α-bromisovaleric acid, which is p..
Product descriptionCorvaltab Meteo® contributes to the maintenance of the normal functional state of the cardiovascular, central and peripheral nervous systems in persons with increased sensitivity to various types of atmospheric influences, including air temperature and humidity, atmospheric p..
Product descriptionLevicitam 250 tablets are indicated as monotherapy (drug of first choice) in the treatment of partial seizures with or without secondary generalization in adults and adolescents aged 16 years and older who are first diagnosed with epilepsy.As an adjunctive therapy for treatment:pa..
Product descriptionTablets "Levicitam 500" are used for the following indications:monotherapy (drug of first choice) in the treatment of: partial seizures with or without secondary generalization in adults and children over 16 years of age who are first diagnosed with epilepsy;as adjunctive therapy ..
Product descriptionMemox tablets are indicated for mild to severe Alzheimer's disease.CompoundActive substance: memantine;1 tablet contains memantine hydrochloride 10 mg or 20 mg;Excipients: lactose, microcrystalline cellulose, talc, colloidal silicon dioxide, magnesium stearate;Mixture for film coa..
Product descriptionMemox tablets are indicated for mild to severe Alzheimer's disease.CompoundActive substance: memantine;1 tablet contains memantine hydrochloride 10 mg or 20 mg;Excipients: lactose, microcrystalline cellulose, talc, colloidal silicon dioxide, magnesium stearate;Mixture for film coa..
Indications.Major depressive disorder. Treatment of major depressive disorder.Obsessive-compulsive disorder. Treatment of symptoms and prevention of relapse of obsessive-compulsive disorder.Panic disorder. Treatment of symptoms and prevention of relapse of panic disorder with or without comorbid ago..
Indications.Major depressive disorder. Treatment of major depressive disorder.Obsessive-compulsive disorder. Treatment of symptoms and prevention of relapse of obsessive-compulsive disorder.Panic disorder. Treatment of symptoms and prevention of relapse of panic disorder with or without comorbid ago..
Pharmacological propertiesQuattrex is a derivative of gamca and phenylethylamine. dominant is its antihypoxic and antiamnestic effect. possesses tranquilizing properties, stimulates memory and learning, increases physical performance; eliminates psycho-emotional tension, anxiety, fear and improves s..
Product descriptionQuetiron® Asino tablets are prescribed for the following indications:Schizophrenia.Bipolar disorder, including manic episodes associated with bipolar disorders; major depressive episodes associated with bipolar disorder.Prevention of relapse in patients with bipolar disorder treat..
Product descriptionQuetiron® Asino tablets are prescribed for the following indications:Schizophrenia.Bipolar disorder, including manic episodes associated with bipolar disorders; major depressive episodes associated with bipolar disorder.Prevention of relapse in patients with bipolar disorder treat..
Product descriptionQuetiron® Asino tablets are prescribed for the following indications:Schizophrenia.Bipolar disorder, including manic episodes associated with bipolar disorders; major depressive episodes associated with bipolar disorder.Prevention of relapse in patients with bipolar disorder treat..
Product descriptionQuetiron® Asino tablets are prescribed for the following indications:Schizophrenia.Bipolar disorder, including manic episodes associated with bipolar disorders; major depressive episodes associated with bipolar disorder.Prevention of relapse in patients with bipolar disorder treat..
Product descriptionQuetiron® Asino tablets are prescribed for the following indications:Schizophrenia.Bipolar disorder, including manic episodes associated with bipolar disorders; major depressive episodes associated with bipolar disorder.Prevention of relapse in patients with bipolar disorder treat..
Pharmacological propertiesPharmacodynamics. Amisulpride is an antipsychotic agent belonging to the class of substituted benzamides. amisulpride selectively, with high affinity binds to d2 / d3 subtypes of dopaminergic receptors. amisulpride has no affinity for serotonin, histamine, adrenergic and ch..
Pharmacological propertiesPharmacodynamics. Amisulpride is an antipsychotic agent belonging to the class of substituted benzamides. amisulpride selectively, with high affinity binds to d2 / d3 subtypes of dopaminergic receptors. amisulpride has no affinity for serotonin, histamine, adrenergic and ch..
Pharmacological propertiesPharmacodynamics. Due to the preservation of energy metabolism in cells experiencing hypoxia or ischemia, trimetazidine prevents a decrease in intracellular ATP levels, thereby ensuring the proper functioning of ion pumps and transmembrane sodium-potassium flow while mainta..
Pharmacological propertiesPharmacodynamics. Due to the preservation of energy metabolism in cells experiencing hypoxia or ischemia, trimetazidine prevents a decrease in intracellular ATP levels, thereby ensuring the proper functioning of ion pumps and transmembrane sodium-potassium flow while mainta..